OBN officials celebrate reclassification of medical marijuana – KTUL
The DEA's proposed reclassification of marijuana to Schedule III creates significant federal marijuana reclassification medical implications for patients and providers. This regulatory shift acknowledges cannabis medical utility while maintaining…
Federal Marijuana Rescheduling Will End Discrimination In Housing, Healthcare And …
Federal cannabis rescheduling patient discrimination policies may soon change as marijuana moves from Schedule I to Schedule III classification. This regulatory shift could eliminate systematic barriers that medical cannabis patients face in housing,…
Access Barriers to GLP-1 Drugs for Childhood Obesity
Pediatric obesity GLP-1 access remains limited due to insurance and systemic barriers. These challenges impact treatment availability for children with obesity and type 2 diabetes. Understanding these access issues is critical for clinicians managing…
GLP-1 Agonist Clinical Evidence: Medicare Cost Reduction
GLP-1 Medicare cost reduction improves treatment initiation and adherence for Medicare beneficiaries. This program lowers financial barriers, enabling better access to GLP-1 therapies. Clinical evidence supports its impact on obesity and cardiometabolic…
In the Mix: 9 More Articles — May 06, 2026
In the Mix — Last 24 HoursMay 06, 2026. 9 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25 High Tide’s Remexian Hits Record 7.6-Tonne Quarter in German Medical Cannabis Market This article…
What Does President Trump’s Executive Order Rescheduling Medical Cannabis Do … – YouTube
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyFederal RegulationMedical…
Industry Stakeholders Welcome Medical Cannabis Regulatory Amendments
Medical cannabis regulatory amendments are crucial for improving patient access and product quality. Stakeholders welcome these changes as they enhance clinical safety and prescribing confidence. Monitoring these amendments helps understand their impact…
Telehealth is widely used by older adults insured by Medicare, new research shows
Telehealth utilization older adults insured by Medicare has increased significantly, improving access to healthcare. This trend offers new opportunities for cannabis medicine clinicians to reach elderly patients. Understanding telehealth utilization…
Trump Reclassified Medical Marijuana: Implications for Arizona
The medical marijuana reclassification Arizona could change how physicians prescribe and document cannabis treatments. This federal shift may improve insurance coverage and clinical integration. Patients and providers should stay informed about evolving…
Colorado cannabis leaders enthusiastic about marijuana rescheduling
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyClinical ResearchFederal…